# Symbiotec Pharmalab

垂直整合甾体 API — 甾体 API 专业、2026 IPO.

Source: https://cn.bioecon.ru/companies/symbiotec/
Updated: 2026-07-20

- 国家: India

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | 26财年为₹869.1 crore | https://mailcontent.icicidirect.com/mailcontent/idirect_symbiotec_iporeview_aug26.pdf, https://mywealthpost.com/symbiotec-pharmalab-ipo-gmp-review-what-you-should-know/, https://patersoncapital.com/symbiotec-pharmalab-ipo-api-leader-seeks-%E2%82%B91757-crore-valuation/ |
| 融资 | 2026年8月IPO(新发行₹150 crore,出售发行₹1,607 crore) | https://mailcontent.icicidirect.com/mailcontent/idirect_symbiotec_iporeview_aug26.pdf, https://mywealthpost.com/symbiotec-pharmalab-ipo-gmp-review-what-you-should-know/, https://www.cnbctv18.com/market/symbiotec-pharmalab-share-price-ipo-listing-today-premium-discount-gmp-signals-issue-price-nse-bse-19980955.htm, https://www.thehindubusinessline.com/portfolio/stock-fundamental-analysis-india/symbiotec-pharmalab-ipo-analysis-key-factors-investors-need-to-know-before-subscribing/article71374910.ece |
| 产能 | 584.67公吨(MT)（化学合成）和700千升(KL)（发酵） | https://mailcontent.icicidirect.com/mailcontent/idirect_symbiotec_iporeview_aug26.pdf, https://mywealthpost.com/symbiotec-pharmalab-ipo-gmp-review-what-you-should-know/, https://www.symbiotec.com/ |
| 生产基地 | 印度中央邦(Madhya Pradesh)的Rau、Pithampur、Ujjain及Mhow | https://mailcontent.icicidirect.com/mailcontent/idirect_symbiotec_iporeview_aug26.pdf, https://mywealthpost.com/symbiotec-pharmalab-ipo-gmp-review-what-you-should-know/, https://www.symbiotec.com/ |
| 认证 | 美国FDA、EU-GMP及WHO-GMP认证 | https://mailcontent.icicidirect.com/mailcontent/idirect_symbiotec_iporeview_aug26.pdf, https://mywealthpost.com/symbiotec-pharmalab-ipo-gmp-review-what-you-should-know/, https://pharma.economictimes.indiatimes.com/news/pharma-industry/symbiotecs-api-edge-makes-a-long-term-case-risk-riders-apply/133449453, https://www.symbiotec.com/ |
| 监管批准 | 美国FDA、欧盟GMP、WHO-GMP、韩国MFDS等 | https://mailcontent.icicidirect.com/mailcontent/idirect_symbiotec_iporeview_aug26.pdf, https://mywealthpost.com/symbiotec-pharmalab-ipo-gmp-review-what-you-should-know/, https://pharma.economictimes.indiatimes.com/news/pharma-industry/symbiotecs-api-edge-makes-a-long-term-case-risk-riders-apply/133449453, https://www.symbiotec.com/ |
| 员工人数 | 截至2026年3月31日超过2,500名员工 | https://mywealthpost.com/symbiotec-pharmalab-ipo-gmp-review-what-you-should-know/ |

独立来源: cnbctv18.com, mailcontent.icicidirect.com, mywealthpost.com, patersoncapital.com, pharma.economictimes.indiatimes.com, thehindubusinessline.com

## 技术

- [生物合成甾体（发酵与生物催化 API）](https://cn.bioecon.ru/technology/biosynthetic-steroids/)